Canagliflozin in Individuals Aged 75 and Older With T2DMCanagliflozin in Individuals Aged 75 and Older With T2DM
Is the SGLT2 inhibitor canagliflozin safe to use in elderly diabetic patients? Journal of the American Geriatrics Society
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news
More News: Canagliflozin | Diabetes | Endocrinology | Geriatrics | Health | Internal Medicine | Invokana | SGLT2 Inhibitors